Intermittent fasting combined with calorie restriction is effective for weight loss and cardio-protection in obese women

Nutrition Journal

Krista A Varady¹  John F Trepanowski¹  Surabhi Bhutani¹  Cynthia M Kroeger¹  Monica C Klempel¹ 

[1] Department of Kinesiology and Nutrition, University of Illinois at Chicago, 1919 West Taylor Street, Room 506F, Chicago, IL, 60612, USA

关键词: Obese women;    Coronary heart disease;    Cholesterol;    Visceral fat;    Body weight;    Liquid diet;    Calorie restriction;    Intermittent fasting;   

Others  :  823833
DOI  :  10.1186/1475-2891-11-98

 received in 2012-08-14, accepted in 2012-11-20,  发布年份 2012

【 摘 要 】

Background

Intermittent fasting (IF; severe restriction 1 d/week) facilitates weight loss and improves coronary heart disease (CHD) risk indicators. The degree to which weight loss can be enhanced if IF is combined with calorie restriction (CR) and liquid meals, remains unknown.

Objective

This study examined the effects of IF plus CR (with or without a liquid diet) on body weight, body composition, and CHD risk.

Methods

Obese women (n = 54) were randomized to either the IFCR-liquid (IFCR-L) or IFCR-food based (IFCR-F) diet. The trial had two phases: 1) 2-week weight maintenance period, and 2) 8-week weight loss period.

Results

Body weight decreased more (P = 0.04) in the IFCR-L group (3.9 ± 1.4 kg) versus the IFCR-F group (2.5 ± 0.6 kg). Fat mass decreased similarly (P < 0.0001) in the IFCR-L and IFCR-F groups (2.8 ± 1.2 kg and 1.9 ± 0.7 kg, respectively). Visceral fat was reduced (P < 0.001) by IFCR-L (0.7 ± 0.5 kg) and IFCR-F (0.3 ± 0.5 kg) diets. Reductions in total and LDL cholesterol levels were greater (P = 0.04) in the IFCR-L (19 ± 10%; 20 ± 9%, respectively) versus the IFCR-F group (8 ± 3%; 7 ± 4%, respectively). LDL peak particle size increased (P < 0.01), while heart rate, glucose, insulin, and homocysteine decreased (P < 0.05), in the IFCR-L group only.

Conclusion

These findings suggest that IF combined with CR and liquid meals is an effective strategy to help obese women lose weight and lower CHD risk.

【 授权许可】

   
2012 Klempel et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Mercuro G, Deidda M, Bina A, Manconi E, Rosano GM: Gender-specific aspects in primary and secondary prevention of cardiovascular disease. Curr Pharm Des 2011, 17(11):1082-1089.
• [2]Lindstrom J, Uusitupa M: Lifestyle intervention, diabetes, and cardiovascular disease. Lancet 2008, 371(9626):1731-1733.
• [3]Mattson MP, Wan R: Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. J Nutr Biochem 2005, 16(3):129-137.
• [4]Harvie MN, Pegington M, Mattson MP, Frystyk J, Dillon B, Evans G, et al.: The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond) 2011, 35(5):714-727.
• [5]Buschemeyer WC 3rd, Klink JC, Mavropoulos JC, Poulton SH, Demark-Wahnefried W, Hursting SD, et al.: Effect of intermittent fasting with or without caloric restriction on prostate cancer growth and survival in SCID mice. Prostate 2010, 70(10):1037-1043.
• [6]Davis C, Curtis C, Tweed S, Patte K: Psychological factors associated with ratings of portion size: relevance to the risk profile for obesity. Eat Behav 2007, 8(2):170-176.
• [7]Heymsfield SB, van Mierlo CA, van der Knaap HC, Heo M, Frier HI: Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Int J Obes Relat Metab Disord 2003, 27(5):537-549.
• [8]Tsai AG, Wadden TA: The evolution of very-low-calorie diets: an update and meta-analysis. Obesity (Silver Spring) 2006, 14(8):1283-1293.
• [9]Mifflin MD, St-Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO: A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr 1990, 51(2):241-247.
• [10]Demerath EW, Reed D, Rogers N, Sun SS, Lee M, Choh AC, et al.: Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels. Am J Clin Nutr 2008, 88(5):1263-1271.
• [11]Demerath EW, Ritter KJ, Couch WA, Rogers NL, Moreno GM, Choh A, et al.: Validity of a new automated software program for visceral adipose tissue estimation. Int J Obes (Lond) 2007, 31(2):285-291.
• [12]Hoefner DM, Hodel SD, O'Brien JF, Branum EL, Sun D, Meissner I, et al.: Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin Chem 2001, 47(2):266-274.
• [13]Williams KV, Mullen ML, Kelley DE, Wing RR: The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes. Diabetes Care 1998, 21(1):2-8.
• [14]Lefevre M, Redman LM, Heilbronn LK, Smith JV, Martin CK, Rood JC, et al.: Caloric restriction alone and with exercise improves CVD risk in healthy non-obese individuals. Atherosclerosis 2009, 203(1):206-213.
• [15]Avenell A, Brown TJ, McGee MA, Campbell MK, Grant AM, Broom J, et al.: What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials. J Hum Nutr Diet 2004, 17(4):317-335.
• [16]Dattilo AM, Kris-Etherton PM: Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992, 56(2):320-328.
• [17]Wronska A, Kmiec Z: Structural and biochemical characteristics of various white adipose tissue depots. Acta Physiol (Oxf) 2012, 205(2):194-208.
• [18]Kosztaczky B, Foris G, Paragh G Jr, Seres I, Zsiros E, Koncsos P, et al.: Leptin stimulates endogenous cholesterol synthesis in human monocytes: New role of an old player in atherosclerotic plaque formation. Leptin-induced increase in cholesterol synthesis. Int J Biochem Cell Biol 2007, 39(9):1637-1645.
• [19]Mantzoros CS, Magkos F, Brinkoetter M, Sienkiewicz E, Dardeno TA, Kim SY, et al.: Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab 2011, 301(4):E567-E584.
• [20]Klempel MC, Varady KA: Reliability of leptin, but not adiponectin, as a biomarker for diet-induced weight loss in humans. Nutr Rev 2011, 69(3):145-154.
• [21]Juhaeri , Stevens J, Chambless LE, Nieto FJ, Jones D, Schreiner P, et al.: Associations of weight loss and changes in fat distribution with the remission of hypertension in a bi-ethnic cohort: the Atherosclerosis Risk in Communities Study. Prev Med 2003, 36(3):330-339.
• [22]Tzotzas T, Evangelou P, Kiortsis DN: Obesity, weight loss and conditional cardiovascular risk factors. Obes Rev 2011, 12(5):e282-e289.
• [23]Vansant G, Hulens M: The assessment of dietary habits in obese women: influence of eating behavior patterns. Eat Disord 2006, 14(2):121-129.
• [24]Racette SB, Das SK, Bhapkar M, Hadley EC, Roberts SB, Ravussin E, et al.: Approaches for quantifying energy intake and%calorie restriction during calorie restriction interventions in humans: the multicenter CALERIE study. Am J Physiol Endocrinol Metab 2012, 302(4):E441-E448.